Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$29.38 +0.89 (+3.12%)
At close: Nov 9, 2026 · 4:00 PM EST

Amphastar Pharmaceuticals (AMPH) Other Accumulated Expenses (2023)

Updated

Amphastar Pharmaceuticals (AMPH) reported Other Accumulated Expenses of $200,000 for Q2 2023.

Analysis

Amphastar Pharmaceuticals (AMPH) Other Accumulated Expenses (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Amphastar Pharmaceuticals 1.25 Bn 156.30 Mn 99.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 200,000.00
API Access

Amphastar Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AMPH&period=max&api_key=YOUR_API_KEY